Virgin Atlantic signs up for SkyCell containers

Virgin Atlantic will offer its customers the option of leasing SkyCell containers for the transportation of pharma shipments.

The airline will use SkyCell containers that can cover the full range of biologics transit temperature requirements, from deep frozen (-80 degrees Celsius) to 25 degrees Celsius.

Dominic Kennedy, managing director at Virgin Atlantic Cargo, said: “The partnership will allow our customers to lease self-charging, temperature-controlled containers to boost the safety and sustainability of their shipments. We look forward to working together to transport crucial vaccines and pharmaceutical products around the world on our global network.”

SkyCell claimed its containers have a run time of 202 hours and a failure rate of 0.1%. The company said the industry-wide failure rate is around 12%.

Share this story

Related Topics

Latest pharma logistics news

Less than a month to enter the Air Cargo News Awards

The entry deadline for the Air Cargo News Awards is fast approaching with just over three weeks to go until…

Read More

Share this story

Geodis strengthens pharma capabilities in Europe

Geodis has strengthened its temperature-controlled pharmaceutical shipment capabilities in Europe by obtaining IATA’s Center of Excellence for Independent Validators in…

Read More

Share this story

DB Schenker widens GDP certification to support pharma shipments

DB Schenker is supporting its pharma business with increased Good Distribution Practice (GDP) compliance. The company now has certifications in…

Read More

Share this story

Damian Brett

Damian Brett
I have been writing about the freight and logistics industry since 2007 when I joined International Freighting Weekly to cover the shipping sector.After a stint in PR, I have gone on to work for Containerisation International and Lloyds List - where I was editor of container shipping - before joining Air Cargo News in 2015.Contact me on [email protected]